Carlsquare: Initiation of Coverage Pharmiva: Launch Should Provide Positive Momentum
Carlsquare Equity Research initiates coverage of Pharmiva with a positive view on the launch of the infection treatment Vernivia. We see good prospects of expected news flow and gradual roll-out to more geographic markets supporting the shares.